Should the Window for Intravenous Administration of Tissue Plasminogen Activator in the Treatment of Acute Ischemic Stroke be Extended to 4.5 Hours?

Authors

  • Tejal Patel Family Health Team
  • Peter S Loewen Vancouver Coastal Health – Providence Health Care, University of British Columbia

DOI:

https://doi.org/10.4212/cjhp.v62i3.798

Downloads

Download data is not yet available.

Downloads

Issue

Section

Point Counterpoint / Le pour et le contre